Bayer Aktiengesellschaft (OTCMKTS:BAYRY – Get Free Report)’s share price passed above its 50 day moving average during trading on Friday . The stock has a 50 day moving average of $5.16 and traded as high as $5.47. Bayer Aktiengesellschaft shares last traded at $5.43, with a volume of 683,003 shares.
Bayer Aktiengesellschaft Stock Performance
The company has a current ratio of 1.32, a quick ratio of 0.81 and a debt-to-equity ratio of 1.19. The stock’s 50-day moving average price is $5.16 and its 200-day moving average price is $6.65. The company has a market capitalization of $21.34 billion, a P/E ratio of -20.88 and a beta of 1.02.
Bayer Aktiengesellschaft (OTCMKTS:BAYRY – Get Free Report) last released its quarterly earnings results on Tuesday, November 12th. The company reported $0.07 EPS for the quarter, missing the consensus estimate of $0.17 by ($0.10). The firm had revenue of $10.96 billion for the quarter. Bayer Aktiengesellschaft had a positive return on equity of 16.90% and a negative net margin of 2.02%. As a group, equities analysts expect that Bayer Aktiengesellschaft will post 1.31 EPS for the current year.
Bayer Aktiengesellschaft Company Profile
Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women’s health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and digital solutions, and contrast agents, as well as cell and gene therapy.
Featured Stories
- Five stocks we like better than Bayer Aktiengesellschaft
- Using the MarketBeat Stock Split Calculator
- J.B. Hunt Leads Truckers Lower: Buy Them While They’re Down?
- Short Selling – The Pros and Cons
- MarketBeat Week in Review – 01/13 – 01/17
- How Can Retail Investors Trade the Toronto Stock Exchange (TSX)?
- Capitalize on the AI Revolution With These 3 ETFs
Receive News & Ratings for Bayer Aktiengesellschaft Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bayer Aktiengesellschaft and related companies with MarketBeat.com's FREE daily email newsletter.